Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450827
Status:
COMPLETED
Last Update Posted:
2015-09-28
First Post:
2007-03-20
Brief Title:
Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center